The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
The Use of Interferon for Emergency Prophylaxis of Marburg Hemorrhagic Fever in Monkeys
Abstract
The possibility of emergency prophylaxis of Marburg hemorrhagic fever with leukocytic and recombinant interferons was studied in experiments on Cercopithecus aethiops. None of the agents protected monkeys from the action of lethal doses of Marburg virus. Recombinant interferon-alpha(2)administered according to the emergency prophylaxis schedule prolonged the mean life-span of monkeys injected with Marburg virus in doses of 100 and 1000 LD50 by 1.9 and 6.1 days, respectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jahrling, P. B., Geisbert, T. W., Geisbert, J. B., Swearengen, J. R., Bray, M., Jaax, N. K., Huggins, J. W., LeDuc, J. W., & Peters, C. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/514310 · Cited by 269
Chronic viral hepatitis C: management update.
Gutfreund, K. S., & Bain, V. G. (2000) · Europe PMC (PubMed Central) · Cited by 34
Therapy of chronic viral hepatitis: a critical view.
Rizzetto, M. (1999) · PubMed · Cited by 12
Winkfield, B., Lunel, F., Beurrier, P., & Calès, P. (2000) · PubMed · Cited by 5
Research works printed but not linked: 7
- A. P. Agafonov, The Study of Immunogenic and Protective Features of Marburg Virus Preparations, Abstract of Cand. Med. Sci. Dissertation, Kol′tsovo (1996).
- S. G. Drozdov and V. P. Sergiev, in: Protection of Non-Endemic Regions from Tropical Viral Hemorrhagic Fevers[in Russian], Moscow (1984), pp. 62-79.
- Yu. E. Serebryanskii, S. S. Afanas′ev, L. A. Denisov, and O. V. Rubal′skii, Voen.-Med. Zh., 320, No. 3, 41-50 (1999).
- E. Bertherat, A. Talarmin, and H. Zeller, Med. Trop., 59, No. 2, 201-204 (1999).
- K. S. Gutfreund and V. G. Bain, CMAJ, 162, No. 6, 827-833 (2000).
- M. Rizzetto, Ital. J. Gastroenterol. Hepatol., 31, No. 8, 781-793 (1999).
- B. Winkfield, F. Lunel, P. Beurrier, and P. Cales, Gastroenterol. Clin. Biol., 24, No. 1, 136-137 (2000).
Cited by
Daddario-DiCaprio, K. M., Geisbert, T. W., Ströher, U., Geisbert, J. B., Grolla, A., Fritz, E. A., Fernando, L., Kagan, E., Jahrling, P. B., Hensley, L. E., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68546-2 · Cited by 184
Clinical Aspects of Marburg Hemorrhagic Fever
Mehedi, M., Groseth, A., Feldmann, H., & Ebihara, H. (2011) · Future Virology · doi:10.2217/fvl.11.79 · Cited by 176
Marty, A. M., Jahrling, P. B., & Geisbert, T. W. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.05.001 · Cited by 165
Emerging Targets and Novel Approaches to Ebola Virus Prophylaxis and Treatment
Choi, J. H., & Croyle, M. A. (2013) · BioDrugs · doi:10.1007/s40259-013-0046-1 · Cited by 87
Early Blood Profiles of Virus Infection in a Monkey Model for Lassa Fever
Djavani, M. M., Crasta, O. R., Zapata, J. C., Fei, Z., Folkerts, O., Sobral, B., Swindells, M. B., Bryant, J., Davis, H., Pauza, C. D., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00536-07 · Cited by 70
Marburg virus disease outbreaks, mathematical models, and disease parameters: a systematic review
Cuomo-Dannenburg, G., McCain, K., McCabe, R., Unwin, H. J. T., Doohan, P., Nash, R. K., Hicks, J. T., Charniga, K., Geismar, C., Lambert, B., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00515-7 · Cited by 65
“The two generation time estimates were based on viral load data from non-human primates under two distinct assumptions, namely that infectiousness is directly proportional to viral load, and alternatively assuming that probability of death is directly proportional to viral load (24,29).”
Transmission Potential and Design of Adequate Control Measures for Marburg Hemorrhagic Fever
Ajelli, M., & Merler, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050948 · Cited by 44
Correlates of Immunity to Filovirus Infection
Bradfute, S. B., & Bavari, S. (2011) · Viruses · doi:10.3390/v3070982 · Cited by 38
Glaze, E. R., Roy, M. J., Dalrymple, L., & Lanning, L. L. (2015) · PubMed Central · Cited by 34
Development of treatment strategies to combat Ebola and Marburg viruses
Paragas, J., & Geisbert, T. W. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.1.67 · Cited by 25
Marburg Virus- A Threat During SARS-CoV-2 Era: A Review
Ashique, S., Chaudhary, V., Pal, S., Panwar, J., Kumar, M., Pramanik, S., Sinha, A., & Mukherjee, A. (2023) · Infectious Disorders - Drug Targets · doi:10.2174/1871526523666230228103845 · Cited by 17
Bausch, D. G., & Peters, C. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-326-4_6 · Cited by 8
Emerging and re-emerging hemorrhagic fever causing viruses in recent years
Ganesh, B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13833-1.00004-1 · Cited by 1
Type I Interferons and Receptors
Pestka, S. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0095
Metadata
- Authors
- Kolokol'tsov, A. A., Davidovich, I. A., Strel'tsova, M. A., Nesterov, A. E., Agafonova, O. A., & Agafonov, A. P.
- Affiliations
- State Research Center of Virology and Biotechnology VECTOR (RU)
- Venue
- Bulletin of Experimental Biology and Medicine
- Published
- 2001-07
- Volume
- 132
- Issue
- 1
- Pages
- 686-688
- ISSN
- 0007-4888 (ISSN-L)
- 1573-8221
- OpenAlex
- W50735278
- Cited by
- 14
- References
- 4
- Citations by year
- 2025: 1 · 2023: 2 · 2015: 1 · 2013: 1 · 2012: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Bulletin of Experimental Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Vectors
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Outbreaks Research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- Marburg hemorrhagic fever, Marburg virus, interferon, vervet monkey, survival prolongation, antiviral defense
- MeSH terms
- Interferon alpha-2, Acute Disease, Animals, Blood, Body Temperature, Chlorocebus aethiops, Guinea Pigs, Humans, Marburg Virus Disease, Recombinant Proteins, Survival, Viremia, Interferon-alpha, Marburgvirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
